Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity

Journal of the American Society of Nephrology

Volumn 17, Issue 4, 2006, Pages 1063-1072

  Li, Yuedan ^a   Shaw, Stephen ^a   Kamsteeg, Erik Jan ^a   Vandewalle, Alain ^b,c   Deen, Peter M T ^a,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AQUAPORIN 2; ARGIPRESSIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DESMOPRESSIN; LITHIUM; MESSENGER RNA; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIDIURESIS; APICAL MEMBRANE; ARTICLE; CELL MEMBRANE; CELL STRAIN; CELL STRAIN MPKCCD; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; HORMONE BLOOD LEVEL; KIDNEY COLLECTING TUBULE; KIDNEY CONCENTRATING CAPACITY; MALE; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TRANSPORT; RAT; RAT STRAIN; RECEPTOR OCCUPANCY;

EID: 33645468796     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005080884     Document Type: Article

References (46)

1. Timmer RT, Sands JM: Lithium intoxication. J Am Soc Nephrol 10: 666-674, 1999
2. Manji HK, Moore GJ, Chen G: Bipolar disorder: Leads from the molecular and cellular mechanisms of action of mood stabilizers. Br J Psychiatry Suppl 41: s107-s119, 2001
3. Phiel CJ, Wilson CA, Lee VM, Klein PS: GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423: 435-439, 2003
4. Harvey BH, Meyer CL, Gallichio VS, Manji HK: Lithium salts in AIDS and AIDS-related dementia. Psychopharmacol Bull 36: 5-26, 2002
5. Ellenhom MJ, Schonwald S, Ordog G, Wasserberger J: Lithium. In: Medical Toxicology: Diagnosis and Treatment of Human Poisoning, edited by Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger J, Baltimore, Williams & Wilkins, 1997, p 1579
6. Stone KA: Lithium-induced nephrogenic diabetes insipidus. J Am Board Fam Pract 12: 43-47, 1999
7. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA: Aquaporins in the kidney: From molecules to medicine. Physiol Rev 82: 205-244, 2002
8. Yasui M, Zelenin SM, Celsi G, Aperia A: Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. Am J Physiol 41: F443-F450, 1997
9. Matsumura Y, Uchida S, Rai T, Sasaki S, Marumo F: Transcriptional regulation of aquaporin-2 water channel gene by cAMP. J Am Soc Nephrol 8: 861-867, 1997
10. Marples D, Frokiaer J, Knepper MA, Nielsen S: Disordered water channel expression and distribution in acquired nephrogenic diabetes insipidus. Proc Assoc Am Physicians 110: 401-406, 1998
11. Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S: Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 95: 1838-1845, 1995
12. Promeneur D, Kwon TH, Frokiaer J, Knepper MA, Nielsen S: Vasopressin V(2)-receptor-dependent regulation of AQP2 expression in Brattieboro rats. Am J Physiol Renal Physiol 279: F370-F382, 2000
13. Walker RJ, Weggery S, Bedford JJ, McDonald FJ, Ellis G, Leader JP: Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers. Kidney Int 67: 291-294, 2005
14. Christensen S, Kusano E, Yusufi AN, Murayama N, Dousa TP: Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats. J Clin Invest 75: 1869-1879, 1985
15. Cogan E, Abramow M: Inhibition by lithium of the hydroosmotic action of vasopressin in the isolated perfused cortical collecting tubule of the rabbit. J Clin Invest 77: 1507-1514, 1986
16. Boton R, Gaviria M, Batlle DC: Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 10: 329-345, 1987
17. Cogan E, Svoboda M, Abramow M: Mechanisms of lithium-vasopressin interaction in rabbit cortical collecting tubule. Am J Physiol 252: F1080-F1087, 1987
18. Goldberg H, Clayman P, Skorecki K: Mechanism of Li inhibition of vasopressin-sensitive adenylate cyclase in cultured renal epithelial cells. Am J Physiol 255: F995-F1002, 1988
19. Hasler U, Mordasini D, Bens M, Bianchi M, Cluzeaud F, Rousselot M, Vandewalle A, Feraille E, Martin PY: Long-term regulation of aquaporin-2 expression in vasopressin-responsive renal collecting duct principal cells. J Biol Chem 277: 10379-10386, 2002
20. Hasler U, Mordasini D, Bianchi M, Vandewalle A, Feraille E, Martin PY: Dual influence of aldosterone on AQP2 expression in cultured renal collecting duct principal cells. J Biol Chem 278: 21639-21648, 2003
21. Bens M, Vallet V, Cluzeaud F, Pascual-Letallec L, Kahn A, Rafestin-Oblin ME, Rossier BC, Vandewalle A: Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J Am Soc Nephrol 10: 923-934, 1999
22. Kamsteeg EJ, Wormhoudt TA, Rijss JPL, van Os CH, Deen PMT: An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J 18: 2394-2400, 1999
23. Deen PMT, Verdijk MAJ, Knoers NVAM, Wieringa B, Monnens LAH, van Os CH, van Oost BA: Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264: 92-95, 1994
24. Deen PMT, Van Balkom BWM, Savelkoul PJ, Kamsteeg EJ, Van Raak M, Jennings ML, Muth TR, Rajendran V, Caplan MJ: Aquaporin-2: COOH terminus is necessary but not sufficient for routing to the apical membrane. Am J Physiol Renal Physiol 282: F330-F340, 2002
25. Deen PMT, Nielsen S, Bindels RJM, van Os CH: Apical and basolateral expression of aquaporin-1 in transfected MDCK and LLC-PK cells and functional evaluation of their transcellular osmotic water permeabilities. Pflugers Arch 433: 780-787, 1997
26. Kishore BK, Chou CL, Knepper MA: Extracellular nucleotide receptor inhibits AVP-stimulated water permeability in inner medullary collecting duct. Am J Physiol 38: F863-F869, 1995
27. Anai H, Ueta Y, Serino R, Nomura M, Kabashima N, Shibuya I, Takasugi M, Nakashima Y, Yamashita H: Upregulation of the expression of vasopressin gene in the paraventricular and supraoptic nuclei of the lithium-induced diabetes insipidus rat. Brain Res 772: 161-166, 1997
28. von Zastrow M: Mechanisms regulating membrane trafficking of G protein-coupled receptors in the endocytic pathway. Life Sci 74: 217-224, 2003
29. Bowen-Pidgeon D, Innamorati G, Sadeghi HM, Birnbaumer M: Arrestin effects on internalization of vasopressin receptors. Mol Pharmacol 59: 1395-1401, 2001
30. Robben JH, Knoers NV, Deen PM: Regulation of the vasopressin v2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell 15: 5693-5699, 2004
31. Dousa TP, Hui YS, Barnes LD: Microtubule assembly in renal medullary slices: Effects of vasopressin, vinblastine, and lithium. J Lab Clin Med 92: 252-261, 1978
32. Servillo G, Della Fazia MA, Sassone-Corsi P: Coupling cAMP signaling to transcription in the liver: Pivotal role of CREB and CREM. Exp Cell Res 275: 143-154, 2002
33. van Balkom BW, Hoffert JD, Chou CL, Knepper MA: Proteomic analysis of long-term vasopressin action in the inner medullary collecting duct of the Brattleboro rat. Am J Physiol Renal Physiol 286: F216-F224, 2004
34. Gonzalez CB, Figueroa CD, Reyes CE, Caorsi CE, Troncoso S, Menzel D: Immunolocalization of V1 vasopressin receptors in the rat kidney using anti-receptor antibodies. Kidney Int 52: 1206-1215, 1997
35. Saito M, Tahara A, Sugimoto T: 1-Desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor. Biochem Pharmacol 53: 1711-1717, 1997
36. Shewey LM, Dorsa DM: V1-type vasopressin receptors in rat brain septum: Binding characteristics and effects on inositol phospholipid metabolism. J Neurosci 8: 1671-1677, 1988
37. Forrest JN Jr, Cohen AD, Torretti J, Himmelhoch JM, Epstein FH: Qn the mechanism of lithium-induced diabetes insipidus in man and the rat. J Clin Invest 53; 1115-1123, 1974
38. Laursen UH, Pihakaski-Maunsbach K, Kwon TH, Ostergaard JE, Nielsen S, Maunsbach AB: Changes of rat kidney AQP2 and Na,K-ATPase mRNA expression in lithium-induced nephrogenic diabetes insipidus. Nephron Exp Nephrol 97: e1-e16, 2004
39. Christensen BM, Marples D, Kim YH, Wang W, Frokiaer J, Nielsen S: Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI. Am J Physiol Cell Physiol 286: C952-C964, 2004
40. Rao R, Zhang MZ, Zhao M, Cai H, Harris RC, Breyer MD, Hao CM: Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria. Am J Physiol Renal Physiol 288: F642-649, 2005
41. Kotnik P, Nielsen J, Kwon TH, Krzisnik C, Frokiaer J, Nielsen S: Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus. Am J Physiol Renal Physiol 288: F1053-F1068, 2005
42. Gould TD, Manji HK: Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30: 1223-1237, 2005
43. Williams RS, Cheng L, Mudge AW, Harwood AJ: A common mechanism of action for three mood-stabilizing drugs. Nature 417: 292-295, 2002
44. Manji HK, Potter WZ, Lenox RH: Signal transduction pathways. Molecular targets for lithium's actions. Arch Gen Psychiatry 52: 531-543, 1995
45. Mork A, Geisler A: A comparative study on the effects of tetracyclines and lithium on the cyclic AMP second messenger system in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 19: 157-169, 1995
46. Wang JF, Asghari V, Rockel C, Young LT: Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells. Neuroscience 91: 771-776, 1999